Tag: biosimilars billing
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Categories
Medications
Archives
Recent-posts
Top 6 Alternatives to Cytotec for Ulcer Prevention in 2024
Nov, 17 2024
Gut Microbiota and Obesity: How Probiotics Influence Weight and Metabolic Health
Jan, 14 2026
Atrial Fibrillation: Rate vs. Rhythm Control and Stroke Prevention
Nov, 26 2025
Top 10 Online Pharmacy Alternatives to CanadaDrugsDirect for Affordable Medication
Dec, 19 2024
Opioids During Pregnancy: Risks, Withdrawal, and Monitoring
Jan, 1 2026